Severino, Patrícia 
; Szymanski, Marcelo; Favaro, Marianna Teixeira de Pinho ; Azzoni, Adriano Rodrigues ; Chaud, Marco Vinicius ; Santana, Maria Helena A ; Silva, Amélia M ; Souto, Eliana B
Source: European Journal of Pharmaceutical Sciences. Unidade: EP
Subjects: LIPÍDEOS, NANOPARTÍCULAS, PROTEÍNAS, NANOTECNOLOGIA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEVERINO, Patrícia et al. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. European Journal of Pharmaceutical Sciences, v. 66, p. 78-82, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2014.09.021. Acesso em: 17 nov. 2024.APA
Severino, P., Szymanski, M., Favaro, M. T. de P., Azzoni, A. R., Chaud, M. V., Santana, M. H. A., et al. (2015). Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy. European Journal of Pharmaceutical Sciences, 66, 78-82. doi:10.1016/j.ejps.2014.09.021NLM
Severino P, Szymanski M, Favaro MT de P, Azzoni AR, Chaud MV, Santana MHA, Silva AM, Souto EB. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy [Internet]. European Journal of Pharmaceutical Sciences. 2015 ; 66 78-82.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejps.2014.09.021Vancouver
Severino P, Szymanski M, Favaro MT de P, Azzoni AR, Chaud MV, Santana MHA, Silva AM, Souto EB. Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy [Internet]. European Journal of Pharmaceutical Sciences. 2015 ; 66 78-82.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejps.2014.09.021
